Ibrahim Assad, J., Merza Hussin, S., Musawi, A., Muhmmed, H. (2016). Relationship between Prostate Sspecific Antigen and Testosterone, Insulin, Adeponectin on Prostate Cancer Patients with Metabolic Syndrome. , 24(7), 1882-1887.
Jaleel Ibrahim Assad; Saad Merza Hussin; AL- Musawi; Hadi Muhmmed. "Relationship between Prostate Sspecific Antigen and Testosterone, Insulin, Adeponectin on Prostate Cancer Patients with Metabolic Syndrome". , 24, 7, 2016, 1882-1887.
Ibrahim Assad, J., Merza Hussin, S., Musawi, A., Muhmmed, H. (2016). 'Relationship between Prostate Sspecific Antigen and Testosterone, Insulin, Adeponectin on Prostate Cancer Patients with Metabolic Syndrome', , 24(7), pp. 1882-1887.
Ibrahim Assad, J., Merza Hussin, S., Musawi, A., Muhmmed, H. Relationship between Prostate Sspecific Antigen and Testosterone, Insulin, Adeponectin on Prostate Cancer Patients with Metabolic Syndrome. , 2016; 24(7): 1882-1887.

Relationship between Prostate Sspecific Antigen and Testosterone, Insulin, Adeponectin on Prostate Cancer Patients with Metabolic Syndrome

Journal of University of Babylon
Article 1, Volume 24, Issue 7, 2016, Pages 1882-1887
Authors
Jaleel Ibrahim Assad; Saad Merza Hussin; AL- Musawi; Hadi Muhmmed
Abstract
Prostate cancer (PCa) is a very common visceral malignancy in men it counts about one-third of all male cancers and it is the second cause of cancer death in males in United States of America. The conduction of this trail is to know the relationship between prostate specific antigen PSA, testosterone T , insulin and adiponectin in prostate cancer patients suffering From metabolic syndrome (MetS). There is significant difference (p< 0.05) in PSA level (39.04 ± 5.05, 2.93± 0.26) ng/ml respectively in prostate cancer group compared with control group.Significant Difference (p<0.05) in prostate cancer testosterone level (2.44±0.15, 3.10± 0.14) ng/ml respectively compared with control group.Significant difference (p<0.05) in prostate cancer adiponectin level (3.82 ±0.12, 4.50± 0.39) µiu/ml respectively compared with control group.Significant difference (p<0.05) in prostate cancer insulin level (6.13±0.86, 3.77± 0.27) µu/ml respectively compared with control group. There is weak negative correlation between PSA and T (-0.29).weak negative correlation between PSA and insulin
(-0.11). Correlation between PSA and adiponectin is undetectable.
Keywords
prostate Cancer; metabolic syndrome; Testosterone; adiponectin; mechanism
Statistics
Article View: 153
PDF Download: 7


Journal Management System. Powered by iJournalPro.com